
NutriLeads Earns ANVISA Clearance for Benicaros in Brazil, Expanding Precision Prebiotic Reach
Key Takeaways
- ANVISA clearance establishes a defined regulatory pathway for incorporating Benicaros SF Pure P into Brazilian supplements, reducing commercialization friction and accelerating finished-product development cycles.
- Brazil’s expanding wellness economy and consumer pull for immune and gut-health claims make it a strategically important launch market, with local distribution support through Kilyos Nutrition.
Regulatory approval from Brazil’s health authority opens the door for Benicaros to enter a fast-growing supplement market, reinforcing global momentum for clinically validated, sustainable gut health ingredients.
NutriLeads BV has secured a key regulatory milestone with approval from ANVISA for its precision prebiotic ingredient Benicaros SF Pure P,1 paving the way for its entry into Brazil’s dietary supplement market.
The decision allows the ingredient to be used in supplements at daily doses of up to 300 mg, confirming its safety and quality while enabling commercial expansion in one of Latin America’s largest and fastest-growing nutrition sectors.
This approval represents a strategic step for NutriLeads as it continues to scale its global footprint and respond to increasing demand for scientifically substantiated gut and immune health solutions. Brazil, with its large consumer base and rising interest in preventive health, is viewed as a critical growth market for functional ingredients.
“We’re thrilled to receive ANVISA’s approval, which marks another important milestone in our global expansion,” said Jan Jongsma, NutriLeads’ CEO. “Brazil represents a key strategic market in Latin America, where demand is growing rapidly for clinically supported, upcycled, and sustainable ingredients that deliver real health benefits.”
What Does ANVISA Approval Mean for Benicaros in Brazil?
The positive opinion from ANVISA signifies that Benicaros SF Pure P meets the agency’s standards for safety, quality, and intended use in dietary supplements. Manufacturers now have a clear regulatory framework for incorporating the ingredient into finished products targeted at Brazilian consumers.
For industry stakeholders, this type of clearance reduces barriers to market entry and accelerates product development timelines. It also signals growing regulatory openness in Brazil to novel, science-backed ingredients, particularly those aligned with global trends in microbiome and immune health.
Why is Brazil an Important Market for Precision Prebiotics?
Brazil’s supplement market has experienced steady growth, driven by heightened consumer awareness of health and wellness, particularly in areas such as digestive health, immunity, and preventive care. The country’s large population have also contributed to increased demand for premium, clinically validated ingredients.
Additionally, local partnerships play a crucial role in market entry. NutriLeads is collaborating with Kilyos Nutrition to support commercialization efforts, ensuring that the ingredient is effectively positioned within Brazil’s competitive supplement landscape.
What Makes Benicaros a Precision Prebiotic?
Benicaros is differentiated by its active component, rhamnogalacturonan-I (cRG-I), a specialized dietary fiber sourced from upcycled carrot pomace. Unlike traditional prebiotics, which can have variable effects depending on an individual’s microbiome, cRG-I is designed to selectively nourish beneficial gut bacteria across diverse microbiome profiles.
This targeted mechanism leads to more predictable increases in short-chain fatty acid production, key metabolites associated with gut health, immune modulation, and overall metabolic function. Clinical research supporting Benicaros has demonstrated its benefits surrounding gut and immune health.2
The “precision” aspect reflects a broader industry shift toward personalized and evidence-based nutrition solutions, where consistency and reproducibility of outcomes are increasingly valued by both consumers and healthcare professionals.
How Does This Approval Fit into NutriLeads’ Global Strategy?
The ANVISA clearance builds on a series of regulatory approvals for Benicaros across Europe, Asia-Pacific, and North America. Collectively, these authorizations reinforce NutriLeads’ strategy of expanding access to clinically validated, plant-based functional ingredients on a global scale.
By establishing regulatory acceptance in multiple regions, the company is better positioned to support multinational brands seeking consistent ingredient solutions across markets. This global footprint also enhances supply chain efficiencies and facilitates broader adoption of precision prebiotics in diverse product formats, including supplements, functional foods, and beverages.
References
1. NutriLeads secures ANVISA approval for Benicaros in Brazil. NutriLeads. Published April 2, 2026. Accessed April 8, 2026.
2. Kerezoudi EN, McKay S, Kurt S, et al. Carrot Rhamnogalacturonan-I supplementation shapes gut microbiota and immune responses: A randomised trial in healthy adults. Microorganisms. 2025; 13(9):2156. https://doi.org/10.3390/microorganisms13092156





